Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidates
2024

New Drug Candidates for Breast Cancer Treatment

Sample size: 194 publication 10 minutes Evidence: high

Author Information

Author(s): Lalagkas Panagiotis N., Melamed Rachel D.

Primary Institution: Department of Biological Sciences, University of Massachusetts, Lowell, MA USA

Hypothesis

If a predisposing disease contributes to breast cancer pathology, identifying the pleiotropic genes related to the risk of cancer could prioritize drugs treating that disease.

Conclusion

The study identifies 59 novel candidate drugs for breast cancer treatment based on shared genetics with predisposing diseases.

Supporting Evidence

  • 84 loci harboring mutations were identified with positively correlated effects between breast cancer and its predisposing diseases.
  • Out of 112 drugs indicated for the predisposing diseases, 74 can be linked to shared genes via pathways.
  • 15 candidate drugs are already in advanced clinical trial phases or approved for breast cancer.

Takeaway

Researchers found new drugs that might help treat breast cancer by looking at genes shared with other diseases that can lead to breast cancer.

Methodology

The study used GWAS summary statistics to identify shared genes and linked them to drugs treating predisposing diseases through canonical pathways.

Potential Biases

Potential bias due to reliance on high-confidence edges in the STRING PPI network.

Limitations

The study relies on GWAS data from European populations, which may miss shared loci in other populations.

Participant Demographics

The study primarily analyzed data from individuals of European ancestry.

Statistical Information

P-Value

7.99e-03

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s40246-024-00688-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication